U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX20230533: GSM7299911: HEK293T, CHIKV-infected, Input, replicate 1; Homo sapiens; Chikungunya virus; RIP-Seq
1 ILLUMINA (NextSeq 500) run: 18.1M spots, 2.7G bases, 1.1Gb downloads

External Id: GSM7299911_r1
Submitted by: Pompeu Fabra University
Study: N6-methyladenosine modification is not a general trait of viral RNA genomes [CHIKV]
show Abstracthide Abstract
N6-methyladenosine (m6A), the most common internal RNA modification in eukaryotic mRNAs, is described to be abundantly present in the genomes of cytoplasmic-replicating RNA viruses. Yet, how the host nuclear m6A writer has access to the viral RNAs in the cytoplasm and what are the associated biological consequences remain unknown. Here, we comprehensively addressed these questions by combining antibody-dependent (m6A-seq) and antibody-independent (SELECT and nanopore direct RNA sequencing) methods on the cytoplasmic-replicating Chikungunya virus (CHIKV) RNA, and found no evidence of m6A modifications. Moreover, depletion of m6A modification machinery components did not affect CHIKV infection, and CHIKV infection did not alter their cellular localization. Consistent with these observations, no m6A modifications were found in the RNA genome of the dengue virus (DENV), another cytoplasmic-replicating virus. Our results challenge the idea that m6A modification is a general trait of cytoplasmic-replicating RNA viruses and stress the need of confirming antibody-dependent detection of m6A modifications with orthogonal antibody-independent methods. Overall design: m6A-RIP on CHIKV-infected HEK293T cells, made up of two input and two IP samples, used to perform downstream peakcalling analysis.
Sample: HEK293T, CHIKV-infected, Input, replicate 1
SAMN34598791 • SRS17559536 • All experiments • All runs
Organism: Homo sapiens
Library:
Name: GSM7299911
Instrument: NextSeq 500
Strategy: RIP-Seq
Source: TRANSCRIPTOMIC
Selection: other
Layout: PAIRED
Construction protocol: Total RNA was extracted using TRIzol (Thermo Fisher) according to the supplier's protocol. TURBO DNA-free Kit (Thermo Fisher) was used to remove any contaminating DNA from RNA samples. Isolated RNA was further purified by ethanol precipitation and 30-40 µg of total RNA were subjected to poly(A)-selection with Dynabeads Oligo (dT)25 (Thermo Fisher) according to the manufacturer's instructions. poly(A)+ RNA from CHIKV-infected HEK293T cells (12 hr p.i. MOI of 4) was fragmented for 10 min at 70°C with RNA fragmentation reagent (Thermo Fisher). After fragmentation, the RNA was cleaned up through an ethanol precipitation step. At this stage, a sample of fragmented poly(A)+ RNA was saved as input RNA for later use in cDNA library construction while 5 μg of fragmented poly(A)+ RNA were used per m6A-IP. For each m6A-immunoprecipitation (m6A-IP), 50 μl of slurry of Magna ChIP Protein G magnetic beads (Sigma-Aldrich) were washed twice with IP/wash buffer 20 mM Tris HCl pH 7.4, 150 mM NaCl, and 0.1% NP-40 (v/v). Beads were re-suspended in 100 μl of IP/wash buffer and coated with 5 μg of rabbit anti-m6A antibody (Active motif, 61495) for 45 min at room temperature with rotation. Beads were then washed 3x with IP/wash buffer and m6A-IPs were prepared by mixing the antibody-coated beads with 910 μl of IP/wash buffer, 35 μl of 0.5 M EDTA pH 8.0, 4 μl of murine RNase inhibitor (New England Biolabs), and 40 μg of fragmented total RNA. 1% input samples (10 μl from the total 1 mL m6A-IP mixture) were removed before immunoprecipitation and stored at −80°C. m6A-IPs were incubated overnight at 4°C with rotation. Beads were then washed 3x with IP/wash buffer. IP samples were further incubated with 126 μl of IP/wash buffer, 15 μl of 10% SDS (v/v) and 9 μl of PCR-grade proteinase K (20 mg/mL) (Thermo Fisher) for 30 min at 55°C. After incubation, 150 μl of the supernatant containing the RNA was transferred to a new microcentrifuge tube and 100 μl of IP/wash buffer was added to each sample. RNA was purified with Trizol LS (Thermo Fisher) and ethanol-precipitated together with 1.5 µl of RNA-grade glycogen (Thermo Fisher). Input samples were processed together with m6A-IPs from the proteinase K treatment onwards. 1 to 5 ng of RNA from input and corresponding m6A-IPs were used for NGS library production following the protocol NEBNext Ultra II directional RNA library prep kit for Illumina (New England Biolabs), treating samples as rRNA-depleted and fragmented RNAs.
Runs: 1 run, 18.1M spots, 2.7G bases, 1.1Gb
Run# of Spots# of BasesSizePublished
SRR2444329018,056,9092.7G1.1Gb2024-01-23

ID:
27650899

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...